Metformin exhibits its therapeutic effect in the treatment of pre-eclampsia via modulating the Met/H19/miR-148a-5p/P28 and Met/H19/miR-216-3p/EBI3 signaling pathways.
Shu C, Yan D, Chen C, Mo Y, Wu L, Gu J, Shah NK, He J, Dong S. Int Immunopharmacol. 2019 Sep; 74:105693. Epub 2019 Jun 13.